Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 28 studies | 32% ± 15% | |
| endothelial cell of lymphatic vessel | 27 studies | 57% ± 18% | |
| macrophage | 23 studies | 34% ± 14% | |
| myeloid cell | 11 studies | 28% ± 12% | |
| dendritic cell | 9 studies | 40% ± 14% | |
| fibroblast | 8 studies | 35% ± 14% | |
| smooth muscle cell | 8 studies | 36% ± 18% | |
| vein endothelial cell | 7 studies | 34% ± 10% | |
| neuron | 7 studies | 31% ± 15% | |
| ciliated cell | 6 studies | 21% ± 5% | |
| capillary endothelial cell | 6 studies | 24% ± 7% | |
| astrocyte | 5 studies | 30% ± 15% | |
| microglial cell | 5 studies | 26% ± 7% | |
| glutamatergic neuron | 5 studies | 32% ± 10% | |
| type II pneumocyte | 4 studies | 19% ± 3% | |
| epithelial cell | 4 studies | 27% ± 9% | |
| connective tissue cell | 4 studies | 34% ± 13% | |
| endothelial cell of vascular tree | 4 studies | 20% ± 5% | |
| GABAergic neuron | 4 studies | 26% ± 12% | |
| oligodendrocyte | 4 studies | 23% ± 5% | |
| type I pneumocyte | 3 studies | 20% ± 5% | |
| classical monocyte | 3 studies | 25% ± 10% | |
| mononuclear phagocyte | 3 studies | 25% ± 9% | |
| tissue-resident macrophage | 3 studies | 25% ± 7% | |
| rod bipolar cell | 3 studies | 24% ± 9% | |
| basal cell | 3 studies | 26% ± 7% | |
| conventional dendritic cell | 3 studies | 25% ± 4% | |
| adipocyte | 3 studies | 21% ± 3% | |
| myoepithelial cell | 3 studies | 24% ± 10% | |
| endothelial cell of sinusoid | 3 studies | 49% ± 31% | |
| respiratory goblet cell | 3 studies | 26% ± 11% | |
| pericyte | 3 studies | 25% ± 7% | |
| alveolar macrophage | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 98% | 3627.21 | 638 / 653 | 91% | 44.81 | 553 / 605 |
| lung | 99% | 5405.53 | 575 / 578 | 89% | 20.75 | 1030 / 1155 |
| breast | 95% | 3882.26 | 436 / 459 | 90% | 15.68 | 1008 / 1118 |
| ovary | 100% | 12938.80 | 180 / 180 | 81% | 17.88 | 349 / 430 |
| uterus | 99% | 13123.37 | 168 / 170 | 79% | 18.03 | 363 / 459 |
| adrenal gland | 100% | 6687.93 | 258 / 258 | 75% | 16.98 | 173 / 230 |
| esophagus | 89% | 14758.37 | 1287 / 1445 | 81% | 17.22 | 149 / 183 |
| bladder | 100% | 11858.24 | 21 / 21 | 54% | 8.73 | 271 / 504 |
| skin | 49% | 1615.04 | 895 / 1809 | 99% | 85.21 | 467 / 472 |
| brain | 44% | 1171.73 | 1155 / 2642 | 98% | 26.48 | 692 / 705 |
| intestine | 84% | 14295.58 | 808 / 966 | 58% | 8.67 | 306 / 527 |
| prostate | 82% | 4153.02 | 200 / 245 | 46% | 4.35 | 232 / 502 |
| stomach | 61% | 6815.88 | 219 / 359 | 66% | 11.01 | 188 / 286 |
| kidney | 39% | 986.62 | 35 / 89 | 68% | 13.53 | 611 / 901 |
| adipose | 100% | 5435.70 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 35.96 | 75 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 17.19 | 41 / 45 |
| pancreas | 0% | 8.37 | 1 / 328 | 90% | 22.87 | 160 / 178 |
| blood vessel | 80% | 3095.63 | 1072 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 8.99 | 22 / 29 |
| spleen | 48% | 1013.71 | 115 / 241 | 0% | 0 | 0 / 0 |
| liver | 8% | 146.86 | 17 / 226 | 19% | 2.18 | 77 / 406 |
| heart | 26% | 535.63 | 222 / 861 | 0% | 0 | 0 / 0 |
| muscle | 3% | 47.52 | 21 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 22.21 | 11 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901166 | Biological process | neural crest cell migration involved in autonomic nervous system development |
| GO_0001525 | Biological process | angiogenesis |
| GO_0003148 | Biological process | outflow tract septum morphogenesis |
| GO_0097491 | Biological process | sympathetic neuron projection guidance |
| GO_1904835 | Biological process | dorsal root ganglion morphogenesis |
| GO_0021675 | Biological process | nerve development |
| GO_0010595 | Biological process | positive regulation of endothelial cell migration |
| GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
| GO_0061551 | Biological process | trigeminal ganglion development |
| GO_0021612 | Biological process | facial nerve structural organization |
| GO_0007155 | Biological process | cell adhesion |
| GO_0048846 | Biological process | axon extension involved in axon guidance |
| GO_0036486 | Biological process | ventral trunk neural crest cell migration |
| GO_0021828 | Biological process | gonadotrophin-releasing hormone neuronal migration to the hypothalamus |
| GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
| GO_0021649 | Biological process | vestibulocochlear nerve structural organization |
| GO_0050919 | Biological process | negative chemotaxis |
| GO_0021637 | Biological process | trigeminal nerve structural organization |
| GO_0061549 | Biological process | sympathetic ganglion development |
| GO_0021785 | Biological process | branchiomotor neuron axon guidance |
| GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
| GO_0097490 | Biological process | sympathetic neuron projection extension |
| GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
| GO_0097374 | Biological process | sensory neuron axon guidance |
| GO_1903375 | Biological process | facioacoustic ganglion development |
| GO_0007411 | Biological process | axon guidance |
| GO_0099175 | Biological process | regulation of postsynapse organization |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0002116 | Cellular component | semaphorin receptor complex |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0030424 | Cellular component | axon |
| GO_0017154 | Molecular function | semaphorin receptor activity |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005021 | Molecular function | vascular endothelial growth factor receptor activity |
| GO_0038023 | Molecular function | signaling receptor activity |
| GO_0019955 | Molecular function | cytokine binding |
| GO_0019838 | Molecular function | growth factor binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NRP2 |
| Protein name | Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2) NRP2 protein (Neuropilin 2, isoform CRA_i) Neuropilin 2 isoform B Neuropilin 2 Neuropilin |
| Synonyms | VEGF165R2 hCG_15204 |
| Description | FUNCTION: High affinity receptor for semaphorins 3C, 3F, VEGF-165 and VEGF-145 isoforms of VEGF, and the PLGF-2 isoform of PGF.; FUNCTION: (Microbial infection) Acts as a receptor for human cytomegalovirus pentamer-dependent entry in epithelial and endothelial cells. . |
| Accessions | B7ZL68 ENST00000357785.10 [O60462-3] ENST00000417189.5 [O60462-6] Q96GU8 ENST00000412873.2 [O60462-2] X5D7M1 C9JH98 ENST00000450507.5 O60462 ENST00000357118.8 [O60462-4] ENST00000272849.7 [O60462-5] ENST00000360409.7 [O60462-1] |